Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Etidronate
Trade Name
Didronel
Risk Category
C
  • Studies on animals show adverse effect and toxicity on fetus.
  • No adequate and well controlled studies done on pregnant women.
  • Drugs should be given only if the potential benefit outweighs the potential risk to the fetus.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

Indication
Indication
  • A systemic bone resorption inhibitor used for treatment of Paget’s disease of bone, hypercalcemia and heterotopic ossification.
  • Fetal Risk
    Fetal Risk
  • Inadequate human studies.
  • Animal studies revealed no increase in teratogenic effects related to oral etidronate.
  • Parenteral use of etidronate in animals was associated with increased incidence of skeletal malformations.
  • Breast Feeding
    Breast Feeding
  • Unknown excretion into human breast milk.
  • Problems have not been documented in humans.
  • Other Trade Names
     
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        You
    Name
    Email
        Your Friend
    Name
    Email
        Comments
     10   +   6    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Result
    Month Day Year